Project Grant HT94252310993
Award Date
9/30/23
Completion Date
9/29/27
Dollars Obligated
$435K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90027, USA
Similar Awards
The Department of Defense's Defense Health Agency awarded a $3,188,604 Project Grant titled "USE OF HIGH-THROUGHPUT SEQUENCING OF THE IMMUNOGLOBULIN LOCI FOR REFINED RISK STRATIFICATION IN PEDIATRIC B-ALL" to Seattle Children's Hospital, doing business as Seattle Children's Research Institute. This grant, funded through the Military Medical Research and Development (CFDA 12.420) program, supports biomedical research related to military medicine, with a focus on cancer, neurological...
The Department of the Army Medical Command awarded a $1,416,000 project grant to Boston Children's Hospital under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to define leukemia stem cells in acute lymphoblastic leukemia from September 2021 through September 2025. Through this funding, Boston Children's Hospital researchers will investigate medical solutions for the battlefield by transforming healthcare for service members and the public. The...
The University of California, Los Angeles (UCLA), through its Office of Research Administration, was awarded a $461,840 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the development of novel therapies against high-grade pediatric glioma, a type of brain cancer, through the creation of innovative multi-omic tools and bioinformatic technologies. As part of this project, UCLA is collaborating with the...
The Defense Health Agency awarded a $1,528,727.00 Project Grant to Children's Research Institute, a subsidiary of Children's National Medical Center, to develop SGT-53, a novel nanomedicine that crosses the blood-brain barrier and augments immunotherapeutic response in pediatric brain cancers. This grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports basic, applied, and advanced biomedical research to transform healthcare for Service Members and the...
The Children's Research Institute received a $709,638 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research efforts from May 2021 through April 2024 to enhance T-cell immunotherapy treatments for pediatric patients with relapsed or refractory solid tumors. The Military Medical Research and Development program supports biomedical research that transforms military and public health...
The Project Grant award of $624,000 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program to the Research Institute at Nationwide Children's Hospital. The funding supports a project titled "SPLICING UP PD-L1 FOR IMMUNOTHERAPY ENHANCEMENT IN PEDIATRIC NEURONAL TUMORS" over a two-year period from September 30, 2023 to September 29, 2025. The goal is to conduct research to advance immunotherapy approaches...
The Department of the Army Medical Command has awarded a $972,555 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Children's Hospital Los Angeles (CHLA) to establish a comprehensive registry for atypical teratoid rhabdoid tumor. The award period runs from July 1, 2025 to June 30, 2029. CHLA, a leading non-profit pediatric academic medical center and research institution, will leverage this federal funding to develop and maintain a specialized registry...
The Department of the Army Medical Command awarded a $2,247,531 project grant to The Children's Hospital of Philadelphia through the Military Medical Research and Development program (CFDA 12.420) to conduct a comprehensive evaluation of immune function in patients receiving multimodal therapy for high-risk neuroblastoma. The four-year project beginning September 1, 2022 will apply basic, applied, and advanced biomedical research approaches to transform pediatric cancer care and investigate...
This $524,340 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is funding the development of a rapid drug discovery pipeline for pediatric acute myelogenous leukemia using machine learning and in vitro feedback loops. The Research Institute of the McGill University Health Centre, a non-profit organization, is conducting this research over a 2-year period from Aug 2023 to Aug 2025. The grant supports transforming healthcare...
The Defense Health Agency awarded a $1,000,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, to support research on the "Diversity of Memory B Cells in Lupus". The 4-year grant, with a period of performance from September 1, 2024 to August 31, 2028, will enable Boston Children's Hospital to conduct biomedical research focused on understanding the role of...